Welcome!

News Feed Item

Arterial Calcification Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Arterial Calcification Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

Arterial Calcification Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Arterial Calcification Global Clinical Trials Review, H2, 2014" provides data on the Arterial Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Calcification. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arterial Calcification. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 5
Arterial Calcification 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Arterial Calcification Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Medestea Internazionale S.p.A. 27
Clinical Trial Overview of Medestea Internazionale S.p.A. 27
Amgen Inc. 28
Clinical Trial Overview of Amgen Inc. 28
Clinical Trial Overview of Top Institutes / Government 29
National Heart, Lung, and Blood Institute 29
Clinical Trial Overview of National Heart, Lung, and Blood Institute 29
Medical University of Lodz 30
Clinical Trial Overview of Medical University of Lodz 30
Romanian Society of Nephrology 31
Clinical Trial Overview of Romanian Society of Nephrology 31
Okayama University 32
Clinical Trial Overview of Okayama University 32
Kingston General Hospital 33
Clinical Trial Overview of Kingston General Hospital 33
Osaka University 34
Clinical Trial Overview of Osaka University 34
Aarhus University 35
Clinical Trial Overview of Aarhus University 35
Mayo Clinic in Rochester 36
Clinical Trial Overview of Mayo Clinic in Rochester 36
National Taiwan University Hospital 37
Clinical Trial Overview of National Taiwan University Hospital 37
University of Kentucky 38
Clinical Trial Overview of University of Kentucky 38
Five Key Clinical Profiles 39
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables

Arterial Calcification Therapeutics, Global, Clinical Trials by Region, 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Arterial Calcification Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medestea Internazionale S.p.A., 2014* 27
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 28
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 29
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Lodz, 2014* 30
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Romanian Society of Nephrology, 2014* 31
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2014* 32
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Kingston General Hospital, 2014* 33
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 34
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 35
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic in Rochester, 2014* 36
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 37
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 38

List of Figures

Arterial Calcification Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 67

To order this report: Arterial Calcification Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
We build IoT infrastructure products - when you have to integrate different devices, different systems and cloud you have to build an application to do that but we eliminate the need to build an application. Our products can integrate any device, any system, any cloud regardless of protocol," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that Ayehu will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara California. Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infras...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex software systems for startups and enterprises. Since 2009 it has grown from a small group of passionate engineers and business...
SYS-CON Events announced today that GrapeUp, the leading provider of rapid product development at the speed of business, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company, specialized in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market acr...
"We are a monitoring company. We work with Salesforce, BBC, and quite a few other big logos. We basically provide monitoring for them, structure for their cloud services and we fit into the DevOps world" explained David Gildeh, Co-founder and CEO of Outlyer, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 21st Int\ernational Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive advantage. By offering a suite of proven hosting and management services, Enzu wants companies to focus on the core of their ...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
While DevOps most critically and famously fosters collaboration, communication, and integration through cultural change, culture is more of an output than an input. In order to actively drive cultural evolution, organizations must make substantial organizational and process changes, and adopt new technologies, to encourage a DevOps culture. Moderated by Andi Mann, panelists discussed how to balance these three pillars of DevOps, where to focus attention (and resources), where organizations might...
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, pane...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
SYS-CON Events announced today that Cloud Academy named "Bronze Sponsor" of 21st International Cloud Expo which will take place October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara, CA. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud com...